Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 30 (HMGN1P30)

Target
HMGN1P30
Molecular classification
Pseudogene, Other
01

Overview

High mobility group nucleosome binding domain 1 pseudogene 30 (HMGN1P30) is a human pseudogene on chromosome 18 that is closely related in sequence to the functional HMGN1 gene. Pseudogenes like HMGN1P30 lack the ability to produce functional protein products and are considered nonfunctional remnants of gene duplication or mutation events. Unlike their parent protein-coding genes, pseudogenes do not serve as therapeutic targets and typically do not play direct roles in cellular function, signal transduction, or disease pathology, unless future research uncovers rare regulatory functions[1][2][4][7]. In summary, HMGN1P30 is a nonfunctional pseudogene and not a recognized therapeutic target. There is nothing to suggest a protein product, drug interactions, mechanisms of action, biomarker use, or safety issues relevant to drug development for this locus.

02

Mechanism of action

None

03

Biological functions

None proven for HMGN1P30 itselfPseudogenes can potentially regulate gene expression via RNA-based mechanisms in rare cases, but this is not reported for HMGN1P30
04

Disease associations

None reported for HMGN1P30 specificallySome pseudogenes, in general, have been implicated in cancer or genetic disorders as regulators, but HMGN1P30 does not appear in such contexts
05

Safety considerations

None relevant; as a pseudogene, HMGN1P30 poses no direct therapeutic safety challenge

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 30 (HMGN1P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 30 (HMGN1P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call